Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Actual-Use Study Awareness Of Physician Influence Urged In Poster

This article was originally published in The Tan Sheet

Executive Summary

Physician guidance to consumers on potential Rx-to-OTC switch drugs should be considered when designing an actual-use study, Bernard Schachtel, MD, Yale University School of Medicine, et al., suggest.

You may also be interested in...

Prilosec GERD Treatment Behavior Shown In Actual Use Studies - FDA

Consumers using AstraZeneca/Procter & Gamble's Prilosec 1 (omeprazole 10 mg) to prevent heartburn are likely to take the drug for longer than the 10-day limit set in proposed OTC labeling, according to agency reviewers.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts